double 33-gauge internal injection cannula c235i-1.2/spc (PlasticsOne inc)
90
Structured Review
PlasticsOne inc
double 33-gauge internal injection cannula c235i-1.2/spc
Double 33 Gauge Internal Injection Cannula C235i 1.2/Spc, supplied by PlasticsOne inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/33-gauge+double+internal+cannulas/26+gauge+guide+cannula/pmc08611193-43-8-13
Average 90 stars, based on 1 article reviews
Double 33 Gauge Internal Injection Cannula C235i 1.2/Spc, supplied by PlasticsOne inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/33-gauge+double+internal+cannulas/26+gauge+guide+cannula/pmc08611193-43-8-13
Average 90 stars, based on 1 article reviews
double 33-gauge internal injection cannula c235i-1.2/spc - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Role of dorsal vagal motor nucleus orexin-receptor-1 in glycemic responses to acute versus repeated insulin administration. Article Snippet: The potent orexigenic neuropeptide, orexin-A (ORX-A), acts at multiple sites within the central neuroaxis to control autonomic responses to energy imbalance, including the dorsal vagal motor nucleus (DMV), where it regulates pancreatic efferent nerve firing.. Recent evidence that recurrent insulin-induced hypoglycemia (RIIH) attenuates lateral hypothalamic ORX-A-ergic neuronal transcriptional activation and prepro-orexin gene expression suggests that this phenotype undergoes functional adaptation to repeated glucoprivation.. We examined the hypothesis that RIIH-associated patterns of ORX-A neurotransmission and/or orexin-receptor-1 (OR-1) expression within the DMV may be correlated with exacerbated hypoglycemic and impaired pancreatic counterregulatory responses to repeated insulin administration. |